Search Results 671-680 of 19711 for Receptor

  1. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    ... receptor (EGFR). Dr. Storz and his research team hope to determine the roles of KRas- and NF-κB-induced signaling pathways in the development and ...

  2. New blood analysis biomarker for patients with lethal prostate cancer could help predict outcomes, personalize treatment and improve survival - Mayo Clinic

    ... receptor signaling inhibitors (ARSIs), is often lethal. Approximately one-third of patients with mCRPC develop lethal resistant disease. Seeking answers on ...

  3. Recurrent Breast Cancer Clinical Trials - Mayo Clinic Research

    ... receptor status, and line of therapy. Subjects will continue protocol directed therapy until documentation of disease progression, development of ...

  4. Fluorescence-guided surgical advancements for patients with ovarian cancer - Mayo Clinic

    Pafolacianine injection for real-time ovarian cancer detection. The phase 3 multicenter study evaluated 109 patients with folate receptor-positive ovarian ...

  5. Clinical trials - Lung Cancer Program

    Patients with known EGFR (Epidermal growth factor receptor) tyrosine kinase (TK) activating mutations and anaplastic lymphoma kinase (ALK) rearrangements ...

  6. Overview - Pharmacogenomics and Drug Targets Laboratory - Mayo Clinic Research

    At the same time, the therapeutic response to those agents varies. For example, aromatase inhibitors used to treat hormonal receptor-positive breast cancer — ...

  7. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    ... receptor (EGFR). Dr. Storz and his research team hope to determine the roles of KRas- and NF-κB-induced signaling pathways in the development and ...

  8. Overview - Pharmacogenomics and Drug Targets Laboratory - Mayo Clinic Research

    At the same time, the therapeutic response to those agents varies. For example, aromatase inhibitors used to treat hormonal receptor-positive breast cancer — ...

  9. John A. Copland, III, Ph.D. - Mayo Clinic Faculty Profiles

    Discoveries from the Copland laboratory include RhoB, transforming growth factor receptor 3 (TBR3) and GATA3 as tumor suppressor genes in addition to FOXO3a ...

  10. Publications - David J. Cangemi, M.D. - Mayo Clinic

    Lacy BE, Cangemi DJ. Opioids and the Gastrointestinal Tract: The Role of Peripherally Active micro-Opioid Receptor Antagonists in Modulating Intestinal ...